Type 2 diabetes is a chronic metabolic disease characterized by high blood glucose resulting from insulin resistance and an eventual decline in insulin production. It arises from a combination of genetic susceptibility and environmental factors, especially excess body weight, physical inactivity and unhealthy diets rich in refined carbohydrates and saturated fats.

In early stages, tissues like muscle and liver become less responsive to insulin, forcing the pancreas to produce more. Over time, pancreatic beta cells become exhausted and insulin secretion falls. This leads to persistent hyperglycemia, which damages blood vessels and organs. Major complications include heart disease, stroke, kidney failure, nerve damage, vision loss and increased infection risk.

Research shows that lifestyle plays a central role in both the development and management of type 2 diabetes. Weight loss, regular physical activity and dietary patterns emphasizing whole grains, vegetables, fruits, legumes, nuts and unsaturated fats can improve insulin sensitivity and sometimes normalize blood sugar, particularly when introduced early. Sleep quality, stress and circadian rhythm disruptions also influence glucose metabolism.

Medications target different mechanisms. Some improve insulin sensitivity, others stimulate insulin secretion, reduce glucose production by the liver or slow carbohydrate absorption. Newer drug classes can promote weight loss and protect the heart and kidneys. In certain cases, metabolic surgery significantly improves glycemic control and can induce remission.

Current research highlights prevention as a realistic goal for many people at high risk. Intervening before sustained hyperglycemia develops greatly reduces long term complications. Large population studies underscore the importance of public health measures that support healthier food environments, physical activity and early screening for impaired glucose regulation.